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We have studied the metabolism of diglycine and triglycine in the
isolated non-filtering rat kidney. Kidneys from adult male Wistar
Kyoto rats weighing 250-350 g were perfused with Krebs-Henseleit
solution containing either 1 mM diglycine or triglycine. The analysis
of the peptide residues and their components was performed using an
amino acid microanalyzer utilizing ion exchange chromatography.
Diglycine was degraded to a final concentration of 0.09 mM after 120
min (91%); this degradation occurred predominantly during the first
hour, with a 56% reduction of the initial concentration. The metabo-
lism of triglycine occurred similarly, with a final concentration of 0.18
mM (82%); during the first hour there was a 67% reduction of the
initial concentration of the tripeptide. Both peptides produced glycine
in increasing concentrations, but there was a slightly lower recovery of
glycine, suggesting its utilization by the kidney as fuel. The hydrolysis
of triglycine also produced diglycine, which was also hydrolyzed to
glycine. The results of the present study show the existence of func-
tional endothelial or contraluminal membrane peptidases which may
be important during parenteral nutrition.
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The investigation of the handling of small
peptides by the kidney is of high clinical
relevance when one considers the utilization
of these compounds during parenteral and
enteral nutrition (1-3), since it is known that
the kidney has the capacity to reabsorb and
metabolize circulating peptides (4). Total
parenteral nutrition could be more beneficial
by replacing solutions containing single
amino acids with solutions containing short-
chain peptides with a high degree of stability
and solubility, which can be made available
by renal hydrolases for protein synthesis or
the generation of energy (4). Thus, studies
have been conducted on animals and hu-
mans utilizing synthetic dipeptides made of
cysteine, tyrosine and glutamine (5) and short-
chain protein hydrolysates containing at least
67% di- and tripeptides (6). These studies
showed that the use of the peptides is safe
and efficient and does not cause deleterious
effects (5,6).
During recent years our group has been
working with peptide metabolism in the kid-
ney using the isolated rat kidney preparation
as a model (4,7). These studies have focused
mainly on the metabolism of oligopeptides
in the isolated perfused rat kidney, which
exhibits both filtering and non-filtering ca-
pabilities (4,7). Recently, we have investi-
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gated the metabolism of the 3 dipeptides
diglycine, prolylglycine and glycylproline in
the non-filtering rat kidney preparation, and
we have shown variable degrees of degrada-
tion depending on the peptide used (7). In
the present report, we are extending our
study to the metabolism of tripeptides, be-
ginning with triglycine.
Adult male Wistar Kyoto rats weighing
250-350 g were fasted for 24 h before the
experiment. The animals were anesthetized
with intraperitoneal sodium pentobarbital (50
mg/kg), and an incision in the linea alba was
made and the right kidney was prepared
according to Fonteles et al. (8). The ureter
was then tied proximal to the kidney and
perfusion was initiated.
The perfusion pressure in the system was
maintained between 100 and 120 mmHg.
The total volume of Krebs-Henseleit solu-
tion, pH 7.3-7.4, in the system was 100 ml.
Di- or triglycine was added to the perfusate
after an equilibration period of 25 min and
samples were collected after 20, 40, 60, 80
and 120 min. The samples were analyzed
using an automated amino acid microanalyzer
according to the method of Hare (9). Aliquots
of 100-200 µl of the kidney perfusate were
diluted with the same volume of 0.05 N HCl
and 0.2 M sodium citrate containing 15%
(w/v) polyethylene glycol and applied di-
rectly to the amino acid analyzer without
further treatment. Chromatography of digly-
cine (Gly-Gly), triglycine (Gly-Gly-Gly) and
glycine (Gly) was performed using a column
packed with Aminex A-5 resin (0.3 x 60 cm)
equilibrated and developed at 55oC with
0.388 M sodium citrate buffer, pH 3.70 (10).
The flow rate of the buffer was 10 ml/h and
ninhydrin was added to the effluent at a flow
rate of 5 ml/h. The times of elution for Gly,
Gly-Gly and Gly-Gly-Gly were 50, 90 and
102 min, respectively. Under these condi-
tions, the relative color yields (height/con-
centration) for glycine, diglycine and trigly-
cine were 1.00, 1.09 and 0.84, respectively.
The column was standardized with 5 nmol
Gly, 10 nmol Gly-Gly and 10 nmol Gly-Gly-
Gly.
Statistical analysis was done using the
Student t-test for paired observations and
data were processed with the Statview pro-
gram in a Performa 750 MacIntosh Com-
puter.
Diglycine disappeared almost completely
after 120 min, with only 0.09 mM of the
intact dipeptide left (Figure 1). This was ex-
pected because a previous experiment per-
formed in our laboratory (7) showed more
than 50% diglycine degradation during the
first hour of perfusion. Similarly, in the pres-
ent study, we observed a 56% degradation
after 60 min. Throughout the period ana-
lyzed a significant decline in diglycine con-
centration was observed compared to the
initial period (Figure 1). Parallel to this deg-
radation, there was the appearance of gly-
cine in increasing concentrations up to 80
min of perfusion, with a slight decline occur-
ring thereafter (Table 1).
Triglycine was significantly degraded
(82%) after 120 min, with a residual concen-
Figure 1 - Metabolism of trigly-
cine (·) and diglycine (!) after
the infusion as a bolus of 1 mM
of each peptide in the isolated
non-filtering rat kidney perfused
with Krebs-Henseleit solution at
pH 7.3-7.4. The system was kept
at 37oC and perfusion pressure
varied from 100-120 mmHg.
Three experiments were done
with diglycine and 8 with trigly-
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tration of 0.18 mM (Figure 1). As with
diglycine, there was considerable hydrolysis
during the first 60 min of perfusion, with a
67% reduction of the tripeptide. Again,
throughout the observation period the values
were significantly different from that of the
initial period of perfusion.
The present results are relevant because
there are no studies describing the metabo-
lism of this tripeptide in the non-filtering rat
kidney. Similar in vivo results were reported
by Adibi and Morse (11) with intravenous
administration of di-, tri- and tetraglycine to
rats. These authors observed a major renal
uptake of these oligopeptides, and their trans-
formation into successively more simple
constitutives, with a slight urinary excretion
(0.2% of the infused concentration) indicat-
ing that hydrolysis probably occurred mainly
in the renal tissues. On this basis we per-
formed the present study on perfused kidney
in order to determine the renal site where
metabolism occurs. It is possible that the
brush border membranes can also influence
oligopeptide metabolism as suggested by oth-
ers (12). However, our results suggest that
potent degradation may be present at other
kidney sites. Also in our model of isolated
perfusion of the non-filtering kidneys, we
observed production of diglycine and gly-
cine utilizing triglycine as a substrate (Table
1). The production of glycine increased dur-
ing perfusion, while the production of
diglycine was relatively constant, allowing
us to suggest that this peptide was continu-
ously hydrolyzed. Similarly, during perfu-
sion with diglycine, we observed a slight
r duction in disposable glycine at the end of
the period.
The recovery of diglycine and triglycine
fragments at the end of each period is shown
in Table 1. For both experiments, there were
similar and constant values up to 80 min, but
fter 120 min we observed a slight reduction
in the final concentration. To determine if
glycine was utilized as a fuel by the kidney,
we performed experiments using this amino
acid as the only substrate. The results showed
a slight decline in the concentration of gly-
cine in the first 80 min of perfusion and at
120 min the final recovery of this amino acid
was about 70%. These results suggest the
uptake and utilization of glycine as fuel by
the perfused organ. Of course, the metabolic
requirements of each organ depend on many
factors and the perfused kidney is a simpli-
fied model. It is possible that glycine has
been partially oxidized or transformed into
other products, such as serine, as demon-
strated previously in our laboratory (4).
Table 1 - Diglycine and glycine accumulation during renal perfusion with Krebs-Henseleit solution in the
presence of 1 mM triglycine (Gly-Gly-Gly) or diglycine (Gly-Gly) and recovery of the fragments.
Conditions of the experiments as described in Figure 1. Results are reported as means ± SEM; 8 experiments
for triglycine and 3 experiments for diglycine and glycine; recovery of triglycine = (Gly-Gly-Gly) + (Gly-Gly) +
(Gly)/3, expressed in %; recovery of diglycine = (Gly-Gly) + (Gly)/2, expressed in %.
Time Gly-Gly-Gly Recovery Gly-Gly Recovery Glycine
(min) (%) (mM) (%) (mM)
Gly-Gly (mM) Gly (mM)
20 0.13 ± 0.04 0.54 ± 0.19 84.0 ± 10.0 0.56 ± 0.03 100.0 ± 0.0 0.94 ± 0.09
40 0.17 ± 0.05 0.76 ± 0.18 82.0 ± 9.0 0.85 ± 0.10 100.0 ± 12.0 0.87 ± 0.16
60 0.19 ± 0.05 1.00 ± 0.21 85.0 ± 8.0 1.20 ± 0.22 104.0 ± 24.0 0.78 ± 0.15
80 0.20 ± 0.05 1.29 ± 0.25 89.0 ± 9.0 1.37 ± 0.30 98.0 ± 25.0 0.76 ± 0.14
120 0.15 ± 0.03 1.66 ± 0.39 70.0 ± 8.0 1.27 ± 0.32 73.0 ± 22.0 0.69 ± 0.17
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Minami et al. (12) studied the metabo-
lism of glycylglycylsarcosine in non-filter-
ing rat kidney. Glycylglycylsarcosine was
hydrolyzed at the Gly-Gly bond, suggesting
the presence of an aminopeptidase in the
peritubular compartment. Since the peptides
used by these authors are different from
those used in the present study, we cannot
directly compare their results to ours. How-
ever, the degradation of Gly-Gly and Gly-
Gly-Gly demonstrated in our study also sug-
gests the presence of peptidases in the endo-
thelium or in contraluminal membranes. Fur-
ther studies on the renal metabolism of
oligopeptides are needed to better under-
stand the metabolic process of their reutil-
ization after delivery to the kidney as hy-
drolysis by-products of larger peptides. The
use of peptides rather than free amino acids
during parenteral nutrition would reduce the
osmolarity of the solutions and provide a
higher density of calories per infused vol-
ume, as has been shown for synthetic dipep-
tides containing cysteine, tyrosine and
glutamine (5).
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